当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析

誉衡药业

(002437)

  

流通市值:54.11亿  总市值:56.31亿
流通股本:21.91亿   总股本:22.80亿

誉衡药业(002437)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.92亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益191453.78万元,未分配利润-73002.13万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产282707.90万元,负债91254.12万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,857,506,712.571,221,310,646.18593,133,301.682,626,039,306.71
营业总成本1,686,482,833.111,108,279,372.88553,364,313.222,489,293,946.97
营业利润222,300,997.03153,266,084.3868,449,052.9175,046,611.96
利润总额222,057,887153,069,234.9468,413,553.7176,778,148.92
净利润191,786,315.95131,525,778.2955,761,035.49128,700,640.73
其他综合收益-388,301225,425.6971,328.17855,100.9
综合收益总额191,398,014.95131,751,203.9855,832,363.66129,555,741.63
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计870,427,011.96874,135,638.921,102,361,285.111,154,449,660.95
非流动资产合计1,956,651,982.421,966,037,524.821,977,503,493.861,998,000,444.24
资产总计2,827,078,994.382,840,173,163.743,079,864,778.973,152,450,105.19
流动负债合计871,852,980.11837,729,658.061,168,200,638.821,412,228,273.02
非流动负债合计40,688,194.5761,410,125.6751,252,306.8629,991,012.54
负债合计912,541,174.68899,139,783.731,219,452,945.681,442,219,285.56
归属于母公司股东权益合计1,893,916,132.241,921,972,954.461,808,476,235.241,661,773,347.48
股东权益合计1,914,537,819.71,941,033,380.011,860,411,833.291,710,230,819.63
负债和股东权益合计2,827,078,994.382,840,173,163.743,079,864,778.973,152,450,105.19
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,184,252,323.731,443,742,278.23751,716,277.43,081,896,412.4
经营活动现金流出小计1,883,749,821.111,241,850,331.22592,476,628.372,807,721,127.83
经营活动产生的现金流量净额300,502,502.62201,891,947.01159,239,649.03274,175,284.57
投资活动现金流入小计31,412,568.9722,142,4008,500,000529,194,239.47
投资活动现金流出小计36,264,769.4523,987,033.6313,256,664.99434,814,506.23
投资活动产生的现金流量净额-4,852,200.48-1,844,633.63-4,756,664.9994,379,733.24
筹资活动现金流入小计218,213,750205,488,750115,488,7501,095,160,000
筹资活动现金流出小计755,655,263.66683,273,443.31280,476,888.091,984,319,557.16
筹资活动产生的现金流量净额-537,441,513.66-477,784,693.31-164,988,138.09-889,159,557.16
汇率变动对现金及现金等价物的影响-674,429.25389,995.57108,159.9987,343.68
现金及现金等价物净增加额-242,465,640.77-277,347,384.36-10,396,994.15-519,617,195.67
期末现金及现金等价物余额468,538,477.75433,656,734.16700,607,124.37711,004,118.52
TOP↑